Literature DB >> 25955625

Hemoptysis: evaluation and management.

John Scott Earwood1, Timothy Daniel Thompson2.   

Abstract

Hemoptysis is the expectoration of blood from the lung parenchyma or airways. The initial step in the evaluation is determining the origin of bleeding. Pseudohemoptysis is identified through the history and physical examination. In adults, acute respiratory tract infections (e.g., bronchitis, pneumonia), bronchiectasis, asthma, chronic obstructive pulmonary disease, and malignancy are the most common causes. Tuberculosis is a major cause of hemoptysis in endemic regions of the world. Although tuberculosis rates are low in the United States, they are increased in persons who are homeless or who were born in other countries; consideration for testing should be made on an individual basis. Hemodynamic instability, abnormal gas exchange, cardiopulmonary comorbidities, and lesions at high risk of massive bleeding warrant inpatient evaluation. Chest radiography is recommended as the initial diagnostic test for hemodynamically stable patients with hemoptysis. Further evaluation with computed tomography with or without bronchoscopy is recommended in patients with massive hemoptysis, those with abnormal radiographic findings, and those with risk factors for malignancy despite normal radiographic findings.

Entities:  

Mesh:

Year:  2015        PMID: 25955625

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  14 in total

1.  A simplified approach to haemoptysis.

Authors:  Zi Yang Trevor Ong; Hui Zhong Chai; Choon How How; Jansen Koh; Teck Boon Low
Journal:  Singapore Med J       Date:  2016-08       Impact factor: 1.858

Review 2.  The Diagnosis and Treatment of Hemoptysis.

Authors:  Harald Ittrich; Maximilian Bockhorn; Hans Klose; Marcel Simon
Journal:  Dtsch Arztebl Int       Date:  2017-06-05       Impact factor: 5.594

Review 3.  Bronchial Artery Embolization.

Authors:  Claire S Kaufman; Sharon W Kwan
Journal:  Semin Intervent Radiol       Date:  2022-08-31       Impact factor: 1.780

4.  An Experience of Being a Patient as a Medical Student.

Authors:  Krisha Shakya
Journal:  JNMA J Nepal Med Assoc       Date:  2022-05-05       Impact factor: 0.556

5.  Predictors of mortality in inflammatory bowel disease patients treated for pneumonia.

Authors:  Offir Ukashi; Yifatch Barash; Michael J Segel; Bella Ungar; Shelly Soffer; Shomron Ben-Horin; Eyal Klang; Uri Kopylov
Journal:  Therap Adv Gastroenterol       Date:  2020-07-31       Impact factor: 4.409

Review 6.  Approach to Hemoptysis in the Modern Era.

Authors:  Sébastien Gagnon; Nicholas Quigley; Hervé Dutau; Antoine Delage; Marc Fortin
Journal:  Can Respir J       Date:  2017-12-21       Impact factor: 2.409

7.  Mitral stenosis due to rheumatic heart disease - A rare cause of massive hemoptysis.

Authors:  Sophie Korzan; Evan Jones; Rahul Mutneja; Prashant Grover
Journal:  Respir Med Case Rep       Date:  2018-03-23

8.  Outcomes and Complications of Bronchial Angioembolization in Patients with Massive Hemoptysis.

Authors:  Seyed Reza Seyyedi; Parham Sadeghipour; Makan Sadr; Omid Shafe; Jamal Moosavi; Oldooz Aloosh; Atefeh Abedini; Babak Sharif-Kashani
Journal:  Tanaffos       Date:  2019-04

9.  Hemoptysis with no malignancy suspected on computed tomography rarely requires bronchoscopy.

Authors:  Christian Lund Petersen; Ulla Møller Weinreich
Journal:  Eur Clin Respir J       Date:  2020-02-06

10.  Concurrent massive hemoptysis and acute pulmonary embolism: A therapeutic dilemma.

Authors:  Sharad Joshi; Ankit Bhatia; Nitesh Tayal; Ritu Verma; Dheeraj Nair
Journal:  Respir Med Case Rep       Date:  2021-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.